Oncolytic Poxviruses

被引：77

作者：

Chan, Winnie M. ^{[1
]}

McFadden, Grant ^{[1
]}

机构：

[1] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA

来源：

ANNUAL REVIEW OF VIROLOGY, VOL 1 | 2014年 / 1卷

关键词：

vaccinia virus; myxoma virus; virus tropism; oncolytic; virotherapeutics; virotherapy; ENVELOPED VACCINIA VIRUS; CANCER-RELATED ANEMIA; MYXOMA-VIRUS; CLINICAL-TRIAL; TUMOR-GROWTH; HUMAN-ERYTHROPOIETIN; APOPTOTIC MIMICRY; THYMIDINE KINASE; IMMUNE-RESPONSES; CELL CARRIERS;

D O I：

10.1146/annurev-virology-031413-085442

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Current standard treatments of cancer can prolong survival of many cancer patients but usually do not effectively cure the disease. Oncolytic virotherapy is an emerging therapeutic for the treatment of cancer that exploits replication-competent viruses to selectively infect and destroy cancerous cells while sparing normal cells and tissues. Clinical and/or preclinical studies on oncolytic viruses have revealed that the candidate viruses being tested in trials are remarkably safe and offer potential for treating many classes of currently incurable cancers. Among these candidates are vaccinia and myxoma viruses, which belong to the family Poxviridae and possess promising oncolytic features. This article describes poxviruses that are being developed for oncolytic virotherapy and summarizes the outcomes of both clinical and preclinical studies. Additionally, studies demonstrating superior efficacy when poxvirus oncolytic virotherapy is combined with conventional therapies are described.

引用

页码：191 / 214

页数：24

共 147 条

[81] Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin [J].

Lun, Xue Qing ;

Zhou, Hongyuan ;

Alain, Tommy ;

Sun, Beichen ;

Wang, Limei ;

Barrett, John W. ;

Stanford, Marianne M. ;

McFadden, Grant ;

Bell, John ;

Senger, Donna L. ;

Forsyth, Peter A. .

CANCER RESEARCH, 2007, 67 (18) :8818-8827

[82] Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors [J].

Lun, Xueqing ;

Ruan, Yibing ;

Jayanthana, Aarthi ;

Liu, David J. ;

Singh, Anjali ;

Trippett, Tanya ;

Bell, John ;

Forsyth, Peter ;

Johnston, Randal N. ;

Narendran, Aru .

MOLECULAR ONCOLOGY, 2013, 7 (05) :944-954

[83] Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin [J].

Lun, XueQing ;

Alain, Tommy ;

Zemp, Franz J. ;

Zhou, Hongyuan ;

Rahman, Masmudur M. ;

Hamilton, Mark G. ;

McFadden, Grant ;

Bell, John ;

Senger, Donna L. ;

Forsyth, Peter A. .

CANCER RESEARCH, 2010, 70 (02) :598-608

[84] Oncolytic vaccinia virus: a silver bullet? [J].

Lusky, Monika ;

Erbs, Philippe ;

Foloppe, Johann ;

Acres, R. Bruce .

EXPERT REVIEW OF VACCINES, 2010, 9 (12) :1353-1356

[85] Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer [J].

Mader, Emily K. ;

Butler, Greg ;

Dowdy, Sean C. ;

Mariani, Andrea ;

Knutson, Keith L. ;

Federspiel, Mark J. ;

Russell, Stephen J. ;

Galanis, Evanthia ;

Dietz, Allan B. ;

Peng, Kah-Whye .

JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11

[86] Inhibitors of C5 complement enhance vaccinia virus oncolysis [J].

Magge, D. ;

Guo, Z. S. ;

O'Malley, M. E. ;

Francis, L. ;

Ravindranathan, R. ;

Bartlett, D. L. .

CANCER GENE THERAPY, 2013, 20 (06) :342-350

[87] Virotherapy clinical trials for regional disease:: In situ immune modulation using recombinant poxvirus vectors [J].

Mastrangelo, MJ ;

Lattime, EC .

CANCER GENE THERAPY, 2002, 9 (12) :1013-1021

[88] Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein [J].

McCabe, VJ ;

Tarpey, I ;

Spibey, N .

VACCINE, 2002, 20 (19-20) :2454-2462

[89]

McCart JA, 2001, CANCER RES, V61, P8751

[90] Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2:: Molecular imaging after systemic delivery using 111In-Pentetreotide [J].

McCart, JA ;

Mehta, N ;

Scollard, D ;

Reilly, RM ;

Carrasquillo, JA ;

Tang, N ;

Deng, H ;

Miller, M ;

Xu, H ;

Libutti, SK ;

Alexander, HR ;

Bartlett, DL .

MOLECULAR THERAPY, 2004, 10 (03) :553-561

← 4 5 6 7 8 9 10 11 12 13 →